World-renowned experts on blood cancers are meeting in San Francisco on September 27-28 to help clinicians stay up-to-date on new, practice changing strategies to manage patients with hematologic malignancies at the NCCN 2019 Annual Congress: Hematologic Malignancies™ presented by the National Comprehensive Cancer Network® (NCCN®), and co-chaired by Ranjana H. Advani, MD, Saul Rosenberg Professor of Lymphoma, Stanford University School of Medicine and Andrew D. Zelenetz, MD, PhD, Medical Director, Quality Informatics, Memorial Sloan Kettering Cancer Center.
The Congress will address new, emerging, and novel therapeutic agents, diagnostics, and other advances in the management of blood cancers. Participants will also explore the growing role of immunotherapies, biosimilars, personalized medicine, and chemotherapeutic options in a rapidly-changing landscape.
The congress takes place at the Hilton San Francisco Union Square, and features the following faculty:
Jeremy S. Abramson, MD, Massachusetts General Hospital Cancer Center
Muhamed Baljevic, MD, University of Nebraska Medical Center, Fred & Pamela Buffett Cancer Center
Rafael Bejar, MD, PhD, UC San Diego Moores Cancer Ce...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).